Swiss National Bank’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-1,274,149
Closed -$226M 2580
2020
Q1
$226M Buy
1,274,149
+239,800
+23% +$45.2M 0.24% 88
2019
Q4
$198M Sell
1,034,349
-48,200
-4% -$8.7M 0.2% 95
2019
Q3
$182M Sell
1,082,549
-1,737
-0.2% -$283K 0.19% 101
2019
Q2
$182M Sell
1,084,286
-41,500
-4% -$5.75M 0.2% 99
2019
Q1
$165M Buy
1,125,786
+22,300
+2% +$3.23M 0.18% 110
2018
Q4
$147M Buy
1,103,486
+21,200
+2% +$3.48M 0.19% 106
2018
Q3
$206M Sell
1,082,286
-10,100
-0.9% -$1.86M 0.23% 87
2018
Q2
$182M Buy
1,092,386
+24,700
+2% +$3.97M 0.21% 98
2018
Q1
$180M Sell
1,067,686
-166,600
-13% -$27.9M 0.22% 100
2017
Q4
$202M Sell
1,234,286
-3,900
-0.3% -$700K 0.22% 98
2017
Q3
$254M Buy
1,238,186
+13,600
+1% +$3.16M 0.29% 71
2017
Q2
$298M Sell
1,224,586
-104,500
-8% -$24.6M 0.35% 54
2017
Q1
$318M Buy
1,329,086
+226,200
+21% +$52.7M 0.4% 43
2016
Q4
$232M Sell
1,102,886
-9,150
-0.8% -$1.9M 0.37% 52
2016
Q3
$256M Sell
1,112,036
-9,700
-0.9% -$2.37M 0.41% 45
2016
Q2
$259M Buy
1,121,736
+86,000
+8% +$19.8M 0.42% 42
2016
Q1
$266M Buy
1,035,736
+307,900
+42% +$88.1M 0.49% 36
2015
Q4
$227M Buy
727,836
+12,700
+2% +$3.78M 0.55% 32
2015
Q3
$194M Buy
715,136
+92,500
+15% +$28.4M 0.5% 35
2015
Q2
$189M Buy
622,636
+30,100
+5% +$8.98M 0.49% 34
2015
Q1
$176M Buy
592,536
+330,098
+126% +$94.1M 0.47% 37
2014
Q4
$67.6M Sell
262,438
-7,900
-3% -$1.97M 0.25% 93
2014
Q3
$65.2M Buy
270,338
+81,957
+44% +$18.3M 0.25% 89
2014
Q2
$42M Sell
188,381
-129,800
-41% -$26.9M 0.16% 157
2014
Q1
$65.5M Sell
318,181
-10,600
-3% -$2.1M 0.26% 85
2013
Q4
$55.2M Buy
328,781
+44,140
+16% +$6.9M 0.22% 116
2013
Q3
$41M Buy
284,641
+16,500
+6% +$2.2M 0.17% 146
2013
Q2
$33.8M Buy
+268,141
New +$30.4M 0.15% 168

Other funds holding AGN

Swiss National Bank's AGN Position: Q2 2020 in Review

Swiss National Bank sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 1,274,149 shares — an estimated $226M sold.

Swiss National Bank first reported a position in AGN in Q2 2013 and held it in 28 quarters. The position peaked at $318M in Q1 2017. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Swiss National Bank reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Swiss National Bank sold 1,274,149 Allergan plc shares in Q2 2020, an estimated $226M.
  • Swiss National Bank first reported a position in Allergan plc in Q2 2013 and held it in 28 quarters.
  • Swiss National Bank's Allergan plc position peaked at $318M in Q1 2017.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Swiss National Bank's 13F filing for Q2 2020, filed 5 Aug 2020.